Varenzin-CA1 for the CKD Cat: The Oral Solution for Anemia

For decades, treating anemia in Chronic Kidney Disease (CKD) cats meant painful injections of human drugs that carried the risk of immune system rejection. In 2023, the FDA conditionally approved a game-changer: Varenzin-CA1 (Molidustat).

This is the first drug specifically designed to treat feline CKD anemia without needles. It works by tricking the cat's body into thinking it is at a high altitude, stimulating natural red blood cell production.

This guide explains how this liquid medication works and why it is replacing the old injectable protocols.

What is Varenzin-CA1?

Varenzin (generic name: Molidustat) is a HIF-PH Inhibitor (Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor).

The Problem (CKD Anemia): Healthy kidneys produce a hormone called Erythropoietin (EPO), which tells the bone marrow to make red blood cells. When kidneys fail, they stop making EPO. The cat becomes anemic, lethargic, and weak.

How Varenzin Works: Instead of injecting fake EPO (like Darbepoetin), Varenzin prevents the breakdown of a protein called HIF (Hypoxia-Inducible Factor).

  • The Signal: HIF is the protein that naturally rises when oxygen is low (like at high altitudes).

  • The Result: By preserving HIF, Varenzin "tricks" the body into producing its own endogenous EPO, even if the kidneys are damaged. This stimulates the bone marrow to create new red blood cells (FDA, 2023).

Varenzin vs. Darbepoetin (The Old Standard)

Until Varenzin, the standard of care was Darbepoetin (Aranesp). Here is how the two treatments compare:

Darbepoetin (The Injectable Option)

  • Administration: Requires a subcutaneous injection every week or every other week.

  • Source: It is a recombinant human protein.

  • Risk of Antibody Reaction: Because it is a human protein, there is a moderate risk that the cat's immune system will recognize it as "foreign" and attack it, causing Pure Red Cell Aplasia (PRCA), which stops red blood cell production entirely.

  • FDA Status: It is an off-label use of a human drug.

Varenzin-CA1 (The Oral Option)

  • Administration: It is an oral liquid given daily at home.

  • Source: It is a synthetic small molecule, not a protein.

  • Risk of Antibody Reaction: There is effectively zero risk of antibody reaction because it stimulates the cat's own EPO production rather than introducing a foreign one.

  • FDA Status: It is the first drug conditionally approved by the FDA specifically for anemia in cats with CKD.

The "Cycle" Dosing Protocol

Varenzin is not given continuously like blood pressure meds. It is given in Cycles.

The 28-Day Cycle:

  1. Treatment Phase: You give the oral liquid once daily for up to 28 days.

  2. The Pause: You MUST stop for at least 7 days.

  3. The Retest: Your vet checks the PCV (Packed Cell Volume) / HCT (Hematocrit).

    • If anemia has returned? Start a new 28-day cycle.

    • If levels are normal? Wait and monitor.

Why the pause? Because the drug is so effective, there is a risk of "Polycythemia" (too many red blood cells). If the blood becomes too thick, it can cause clots. The pause ensures safety.

Dosage and Administration

⚠️ DISCLAIMER: The following information is for educational purposes only. Dosage must be calculated by a veterinarian. This drug requires strict monitoring.

  • Form: A liquid suspension (25 mg/mL).

  • Dosage: 5 mg/kg (2.3 mg/lb) orally once daily.

  • Handling: It comes with a specific syringe. Do not wash or disassemble the syringe between uses (just wipe it), as water can degrade the medication.

Side Effects: What to Watch For

1. Vomiting (The #1 Side Effect)

  • In studies, about 50% of cats vomited at least once.

  • Tip: Giving it with a small amount of food may help reduce nausea.

2. Polycythemia (Thick Blood)

  • If the drug works too well, red blood cell count gets too high. This turns the blood into "sludge," risking stroke or clots.

  • Monitoring: This is why weekly blood checks are required starting around Day 14 of the cycle.

3. Hypertension (High Blood Pressure)

  • As blood volume increases, pressure may rise. Monitor BP closely if your cat is already hypertensive.

4. Seizures (Use with Caution)

  • Varenzin should be used with extreme caution in cats with a history of seizures or epilepsy, as it may lower the seizure threshold (Elanco, 2023).

Safety Warnings for Humans

Pregnant Women Warning: Women who are pregnant or may become pregnant should exercise extreme caution or avoid handling Varenzin. The drug is designed to alter fetal hemoglobin production and can be dangerous to a developing fetus. Wear gloves.

Summary for the Caretaker

Varenzin represents a massive leap forward, allowing you to treat anemia at home without needles.

  • Follow the Cycle: Respect the 28-day limit and the 7-day pause.

  • Check the Blood: You cannot skip the recheck appointments; "thick blood" is just as dangerous as "thin blood."

  • Watch for Vomiting: If your cat vomits immediately after dosing, do not re-dose that day. Wait until the next scheduled dose.

References

  • FDA. (2023). FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease. U.S. Food and Drug Administration.

  • Elanco. (2023). Varenzin-CA1 (molidustat oral suspension) Freedom of Information Summary.

  • Chalhoub, S., et al. (2012). The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats. Journal of Veterinary Internal Medicine.

  • Jepson, R. E. (2020). Management of complications of CKD: Anemia. In: BSAVA Manual of Feline Nephrology and Urology.